Highline Capital Management’s Amgen AMGN Stock Holding History

Highline Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-388,537	Closed	-$61.9M	–	42
2014 Q4	$61.9M	Sell	388,537 -140,600	-27%	-$21.9M	2.57%	19
2014 Q3	$74.3M	Buy	529,137 +398,087	+304%	+$52M	2.9%	15
2014 Q2	$15.5M	Buy	131,050 +3,050	+2%	+$353K	0.79%	30
2014 Q1	$15.8M	Buy	128,000 +117,000	+1,064%	+$14.2M	1.08%	24
2013 Q4	$1.25M	Sell	11,000 -711,300	-98%	-$80.9M	0.08%	28
2013 Q3	$80.8M	Buy	+722,300	New	+$78.3M	5.44%	2

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Highline Capital Management's AMGN Position: Q1 2015 in Review

Highline Capital Management sold out of Amgen (AMGN) in Q1 2015, closing a stake of 388,537 shares — an estimated $61.9M sold.

Highline Capital Management first reported a position in AMGN in Q3 2013 and held it in 6 quarters. The position peaked at $80.8M in Q3 2013. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

Highline Capital Management reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
Highline Capital Management sold 388,537 Amgen shares in Q1 2015, an estimated $61.9M.
Highline Capital Management first reported a position in Amgen in Q3 2013 and held it in 6 quarters.
Highline Capital Management's Amgen position peaked at $80.8M in Q3 2013.
1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Highline Capital Management's 13F filing for Q1 2015, filed 15 May 2015.